MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

Clinical trial NCT06277154 · RECRUITING

Trial details

NCT number: NCT06277154
Sponsor: HRYZ Biotech Co.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Leiomyosarcoma Liposarcoma Synovial Sarcoma Angiosarcoma Undifferentiated Pleomorphic Sarcoma Epithelioid Sarcoma Malignant Peripheral Nerve Sheath Tumors Fibrosarcoma Pleomorphic Rhabdomyosarcoma Endometrial Stromal Sarcoma Desmoplastic Small Round Cell Tumor

Start date: 2024-02-21
Primary completion: 2026-02-01
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.